000 | 01263 a2200361 4500 | ||
---|---|---|---|
005 | 20250512035634.0 | ||
264 | 0 | _c19881222 | |
008 | 198812s 0 0 eng d | ||
022 | _a0277-3732 | ||
024 | 7 |
_a10.1097/00000421-198812000-00013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCreagan, E T | |
245 | 0 | 0 |
_aRecombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term responders. _h[electronic resource] |
260 |
_bAmerican journal of clinical oncology _cDec 1988 |
||
300 |
_a652-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon Type I _xtherapeutic use |
650 | 0 | 4 |
_aInterferon-gamma _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelanoma _xtherapy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRecombinant Proteins |
700 | 1 | _aSchaid, D J | |
700 | 1 | _aAhmann, D L | |
700 | 1 | _aFrytak, S | |
773 | 0 |
_tAmerican journal of clinical oncology _gvol. 11 _gno. 6 _gp. 652-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-198812000-00013 _zAvailable from publisher's website |
999 |
_c3148045 _d3148045 |